As of November 2024 Paradigm Biopharmaceuticals has 289.68M shares outstanding, a increase of 20.22% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 289.68M | 20.22% |
2022 | 240.96M | 13.56% |
2021 | 212.19M | - |